Ross Warshauer
Private-Equity-Analyst bei 3i US
Aktive Positionen von Ross Warshauer
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
3i US
 3i US Investment ManagersFinance 3i U.S. is a venture capital firm headquartered in Menlo Park, California. The firm is a subsidiary of 3i Group Plc (LSE: III). | Private-Equity-Analyst | 01.09.2021 | - |
Karriereverlauf von Ross Warshauer
Ehemalige bekannte Positionen von Ross Warshauer
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
ten23 Health AG
 ten23 Health AG BiotechnologyHealth Technology ten23 Health AG, founded in 2021, is a Swiss pharmaceutical company that specializes in designing, characterizing, and validating the manufacturing process for stability and preclinical purposes. The company is based in Basel, Switzerland, and has subsidiaries in Switzerland. The company is the partner of choice for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow ’ s medicines. The company's team of experts can test and evaluate the stability of a vast range of therapeutic modalities. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Ross Warshauer
| Goizueta Business School-Emory | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Schweiz | 2 |
Operativ
| Private Equity Analyst | 1 |
| Undergraduate Degree | 1 |
| Director/Board Member | 1 |
Sektoral
| Finance | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
3i US
3i US Investment ManagersFinance 3i U.S. is a venture capital firm headquartered in Menlo Park, California. The firm is a subsidiary of 3i Group Plc (LSE: III). | Finance |
ten23 Health AG
ten23 Health AG BiotechnologyHealth Technology ten23 Health AG, founded in 2021, is a Swiss pharmaceutical company that specializes in designing, characterizing, and validating the manufacturing process for stability and preclinical purposes. The company is based in Basel, Switzerland, and has subsidiaries in Switzerland. The company is the partner of choice for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow ’ s medicines. The company's team of experts can test and evaluate the stability of a vast range of therapeutic modalities. | Health Technology |
- Börse
- Insiders
- Ross Warshauer
- Erfahrung
